Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN)

https://www.aslanpharma.com

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/04/2018

Market Cap

1,697,010

Shares Outstanding

416,810,000

Weighted SO

16,672,455

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

GLUE --.--%

NAMS --.--%

IVA --.--%

CGEM --.--%

CMPX --.--%

GPCR --.--%

IOBT --.--%

ERAS --.--%

LYRA --.--%

Beta

1.3990

Last Div

0.0000

Range

0.475-17.52

Chg

-0.0999

Avg Vol

101618

Mkt Cap

1697010

Exch

NASDAQ

Country

SG

Phone

65 6222 4235

DCF Diff

0.5565

DCF

0.0435

Div Yield

0.0000

P/S

0.1414

EV Multiple

-0.3217

P/FV

-0.6236

Div Yield %

0.0000

P/E

-0.3198

PEG

-0.0119

Payout

0.0000

Current Ratio

1.0496

Quick Ratio

1.0496

Cash Ratio

0.9384

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-2.9103

Pretax Margin

-2.9084

Net Margin

-2.9189

Eff Tax Rate

-0.0226

ROA

-1.6689

ROE

5.4383

ROCE

-25.2212

NI/EBT

1.0036

EBT/EBIT

0.9993

EBIT/Rev

-2.9103

Debt Ratio

1.2705

D/E

-1.4843

LT Debt/Cap

13.9739

Total Debt/Cap

3.0648

Int Coverage

-8.9136

CF/Debt

0.0000

Equity Multi

-1.1683

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

68.0295

Asset Turnover

0.5717

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

0.9853

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.6236

P/B

-0.6236

P/S

0.1414

P/E

-0.3198

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.0119

P/S

0.1414

EV Multiple

-0.3217

P/FV

-0.6236

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 08, 06:45 ASLAN Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Revenue Product Segmentation